English

enVVeno Medical Corporation

EDGAR

HJLI Quarterly report (10-Q) · filed 2026-10-29

53 filing records in this dataset, filed from 2017-09-07 to 2026-10-29. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2019 Q4 · USD

Exact inputs and evidence

Revenue: 31243 USD Source
Revenue: 31243 USD Source

Operating cash flow

-1.62 million USD

2019 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: -5896400 USD Source
Operating Cash Flow: -4273179 USD Source

Free cash flow

-1.64 million USD

2019 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: -5896400 USD Source
Operating Cash Flow: -4273179 USD Source
Capital Expenditure: 363891 USD Source
Capital Expenditure: 350934 USD Source

Cash and cash equivalents: 2.59 million USD 2026-09-30 Source
Exact value

2585000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 695 thousand shares 2026-09-30 Source
Exact value

695000 shares

Reported share-count change

-96.56% · -19.5 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

20216000 shares · 2025-09-30· Source
695000 shares · 2026-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

31.2 thousand USD

2019-01-01 – 2019-12-31

Exact inputs and evidence

Revenue: 31243 USD · 2019-01-01 – 2019-03-31 Source
Revenue: 31243 USD · 2019-01-01 – 2019-06-30 Source
Revenue: 31243 USD · 2019-01-01 – 2019-03-31 Source
Revenue: 31243 USD · 2019-01-01 – 2019-09-30 Source
Revenue: 31243 USD · 2019-01-01 – 2019-06-30 Source
Revenue: 31243 USD · 2019-01-01 – 2019-12-31 Source
Revenue: 31243 USD · 2019-01-01 – 2019-09-30 Source

Net income

-15.6 million USD

2025-10-01 – 2026-09-30

Exact inputs and evidence

Net income: -19472000 USD · 2025-01-01 – 2025-12-31 Source
Net income: -15736000 USD · 2025-01-01 – 2025-09-30 Source
Net income: -3849000 USD · 2026-01-01 – 2026-03-31 Source
Net income: -3600000 USD · 2026-04-01 – 2026-06-30 Source
Net income: -4367000 USD · 2026-07-01 – 2026-09-30 Source

Operating cash flow

-13.4 million USD

2025-10-01 – 2026-09-30

Exact inputs and evidence

Operating cash flow: -15568000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -12125000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -3238000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -6787000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: -3238000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -9965000 USD · 2026-01-01 – 2026-09-30 Source
Operating cash flow: -6787000 USD · 2026-01-01 – 2026-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-29.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 3 of 11 periods available· newest 2019-12-31
Operating income: 9 of 11 periods available· newest 2025-12-31
Net income: 9 of 11 periods available· newest 2025-12-31
Operating cash flow: 9 of 11 periods available· newest 2025-12-31
Capital expenditure: 9 of 11 periods available· newest 2025-12-31
Total assets: 9 of 11 periods available· newest 2025-12-31
Total liabilities: 9 of 11 periods available· newest 2025-12-31
Current assets: 9 of 11 periods available· newest 2025-12-31
Current liabilities: 8 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 9 of 11 periods available· newest 2025-12-31
long term debt: No compatible figures in this window
Shares outstanding: 9 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
+USD 2.35 million

Prior period

−USD 21.82 million

2024-01-01 – 2024-12-31
Current period

−USD 19.47 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-19472000 − -21819000 = 2347000 USD

-21819000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-19472000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · enVVeno Medical Corporation · 2025-12-31 enVVeno Medical Corporation (edgar:1661053) Year-over-year change in Net income: 2347000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:57:08Z Snapshot: cbf24923a26c38816f33be15db6db6f84dba035d4c14f6dddae1b801f75c518c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1661053?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -19472000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1661053/000149315226012928/form10-k.htm#1288680 Filing: 000149315226012928 Input fundies:NetIncome: -21819000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1661053/000149315226012928/form10-k.htm#1289604 Filing: 000149315226012928
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 1.27 million

Prior period

−USD 16.84 million

2024-01-01 – 2024-12-31
Current period

−USD 15.57 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-15568000 − -16838000 = 1270000 USD

-16838000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-15568000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · enVVeno Medical Corporation · 2025-12-31 enVVeno Medical Corporation (edgar:1661053) Year-over-year change in Operating cash flow: 1270000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:57:08Z Snapshot: cbf24923a26c38816f33be15db6db6f84dba035d4c14f6dddae1b801f75c518c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1661053?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -15568000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1661053/000149315226012928/form10-k.htm#939304 Filing: 000149315226012928 Input fundies:OperatingCashFlow: -16838000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1661053/000149315226012928/form10-k.htm#939775 Filing: 000149315226012928
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-86.5%

Prior period

USD 37,000

2024-01-01 – 2024-12-31
Current period

USD 5,000

2025-01-01 – 2025-12-31

Exact inputs and evidence

5000 − 37000 = -32000 USD

37000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
5000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · enVVeno Medical Corporation · 2025-12-31 enVVeno Medical Corporation (edgar:1661053) Year-over-year change in Capital expenditure: -32000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:57:08Z Snapshot: cbf24923a26c38816f33be15db6db6f84dba035d4c14f6dddae1b801f75c518c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1661053?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 5000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1661053/000149315226012928/form10-k.htm#943308 Filing: 000149315226012928 Input fundies:CapitalExpenditure: 37000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1661053/000149315226012928/form10-k.htm#943765 Filing: 000149315226012928
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2019 2019-01-01 – 2019-12-31

Revenue USD 31,243 100% of revenue
Operating costs Derived USD 7.71 million 24,667% of revenue
Operating income −USD 7.68 million −24,567% of revenue
Tax, interest and other Derived −USD 49,915 −160% of revenue
Net income −USD 7.63 million −24,407% of revenue

Cash

Operating cash flow −USD 5.9 million −18,873% of revenue
Capital expenditure USD 363,891 1,165% of revenue
Free cash flow Derived −USD 6.26 million −20,037% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2017 Operating loss: operating costs were 1,546% of revenue.
2018 Operating loss: operating costs were 4,311% of revenue.
2019 Operating loss: operating costs were 24,667% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2017 2017-01-01 – 2017-12-31	422111	6525358 Derived	-6103247	1688222 Derived	-7791469	-4213178 Derived	Source 2017-01-01 – 2017-12-31: 422111 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -6103247 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -7791469 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -4202240 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 10938 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	186552	8041337 Derived	-7854785	5187924 Derived	-13042709	-6368260 Derived	Source 2018-01-01 – 2018-12-31: 186552 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -7854785 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -13042709 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -6355838 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 12422 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	31243	7706555 Derived	-7675312	-49915 Derived	-7625397	-6260291 Derived	Source 2019-01-01 – 2019-12-31: 31243 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -7675312 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -7625397 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -5896400 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 363891 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 31.2K 2019

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20172017-12-31	Revenue	422111	Revenue: 422111 Open source
20182018-12-31	Revenue	186552	Revenue: 186552 Open source
20192019-12-31	Revenue	31243	Revenue: 31243 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-83.3% 2019

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20172017-12-31	Year over year	No prior comparable period	Revenue: 422111 Open source
20182018-12-31	Year over year	-55.8%	Revenue: 186552 Open source Revenue: 422111 Open source
20192019-12-31	Year over year	-83.3%	Revenue: 31243 Open source Revenue: 186552 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -24,566.5% 2019

Net margin -24,406.7% 2019

Free cash flow margin -20,037.4% 2019

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20172017-12-31	Operating margin	-1,445.9%	Operating Income: -6103247 Open source Revenue: 422111 Open source
20182018-12-31	Operating margin	-4,210.5%	Operating Income: -7854785 Open source Revenue: 186552 Open source
20192019-12-31	Operating margin	-24,566.5%	Operating Income: -7675312 Open source Revenue: 31243 Open source
20172017-12-31	Net margin	-1,845.8%	Net Income: -7791469 Open source Revenue: 422111 Open source
20182018-12-31	Net margin	-6,991.5%	Net Income: -13042709 Open source Revenue: 186552 Open source
20192019-12-31	Net margin	-24,406.7%	Net Income: -7625397 Open source Revenue: 31243 Open source
20172017-12-31	Free cash flow margin	-998.1%	Revenue: 422111 Open source Operating Cash Flow: -4202240 Open source Capital Expenditure: 10938 Open source
20182018-12-31	Free cash flow margin	-3,413.7%	Revenue: 186552 Open source Operating Cash Flow: -6355838 Open source Capital Expenditure: 12422 Open source
20192019-12-31	Free cash flow margin	-20,037.4%	Revenue: 31243 Open source Operating Cash Flow: -5896400 Open source Capital Expenditure: 363891 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -5.9M 2019

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20172017-12-31	Operating cash flow	-4202240	Operating Cash Flow: -4202240 Open source
20182018-12-31	Operating cash flow	-6355838	Operating Cash Flow: -6355838 Open source
20192019-12-31	Operating cash flow	-5896400	Operating Cash Flow: -5896400 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -6.3M 2019

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20172017-12-31	Free cash flow	-4213178	Operating Cash Flow: -4202240 Open source Capital Expenditure: 10938 Open source
20182018-12-31	Free cash flow	-6368260	Operating Cash Flow: -6355838 Open source Capital Expenditure: 12422 Open source
20192019-12-31	Free cash flow	-6260291	Operating Cash Flow: -5896400 Open source Capital Expenditure: 363891 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

71.2% 2019

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20172017-12-31	Liabilities / assets	369.1%	Total Liabilities: 8174584 Open source Total Assets: 2214888 Open source
20182018-12-31	Liabilities / assets	42.8%	Total Liabilities: 1522993 Open source Total Assets: 3559436 Open source
20192019-12-31	Liabilities / assets	71.2%	Total Liabilities: 2444260 Open source Total Assets: 3434200 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.76× 2019

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20172017-12-31	Current assets / current liabilities	Not reported	Current Assets: 170413 Open source
20182018-12-31	Current assets / current liabilities	1.86×	Current Assets: 2836973 Open source Current Liabilities: 1522993 Open source
20192019-12-31	Current assets / current liabilities	0.76×	Current Assets: 1423878 Open source Current Liabilities: 1876312 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2017 2017-01-01 – 2017-12-31	−USD 7.79 million Exact value Exact value: -7791469 USD 2017-01-01 – 2017-12-31: -7791469 USD Inspect Net Income Open source Share or cite Citation for Net Income · enVVeno Medical Corporation · 2017-12-31 enVVeno Medical Corporation (edgar:1661053) Net Income: -7791469 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:57:08Z Snapshot: cbf24923a26c38816f33be15db6db6f84dba035d4c14f6dddae1b801f75c518c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1661053/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -7791469 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1661053/000149315219003283/hjli-20181231.xml#182960 Filing: 000149315219003283 The citation records this snapshot. The page link may show a newer release later.	−USD 4.2 million Exact value Exact value: -4202240 USD 2017-01-01 – 2017-12-31: -4202240 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · enVVeno Medical Corporation · 2017-12-31 enVVeno Medical Corporation (edgar:1661053) Operating Cash Flow: -4202240 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:57:08Z Snapshot: cbf24923a26c38816f33be15db6db6f84dba035d4c14f6dddae1b801f75c518c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1661053/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4202240 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1661053/000149315219003283/hjli-20181231.xml#570421 Filing: 000149315219003283 The citation records this snapshot. The page link may show a newer release later.	USD 10,938 Exact value Exact value: 10938 USD 2017-01-01 – 2017-12-31: 10938 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · enVVeno Medical Corporation · 2017-12-31 enVVeno Medical Corporation (edgar:1661053) Capital Expenditure: 10938 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:57:08Z Snapshot: cbf24923a26c38816f33be15db6db6f84dba035d4c14f6dddae1b801f75c518c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1661053/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 10938 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1661053/000149315219003283/hjli-20181231.xml#210341 Filing: 000149315219003283 The citation records this snapshot. The page link may show a newer release later.	−USD 4.21 million Calculation and evidence -4202240 − 10938 USD Exact free cash flow: -4213178 USD 2017-01-01 – 2017-12-31: -4202240 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 10938 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · enVVeno Medical Corporation · 2017-12-31 enVVeno Medical Corporation (edgar:1661053) Free cash flow: -4213178 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:57:08Z Snapshot: cbf24923a26c38816f33be15db6db6f84dba035d4c14f6dddae1b801f75c518c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1661053?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -4202240 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1661053/000149315219003283/hjli-20181231.xml#570421 Filing: 000149315219003283 Input fundies:CapitalExpenditure: 10938 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1661053/000149315219003283/hjli-20181231.xml#210341 Filing: 000149315219003283 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 13.04 million Exact value Exact value: -13042709 USD 2018-01-01 – 2018-12-31: -13042709 USD Inspect Net Income Open source Share or cite Citation for Net Income · enVVeno Medical Corporation · 2018-12-31 enVVeno Medical Corporation (edgar:1661053) Net Income: -13042709 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:57:08Z Snapshot: cbf24923a26c38816f33be15db6db6f84dba035d4c14f6dddae1b801f75c518c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1661053/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -13042709 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1661053/000149315220023963/hjli-20200930.xml#258001 Filing: 000149315220023963 The citation records this snapshot. The page link may show a newer release later.	−USD 6.36 million Exact value Exact value: -6355838 USD 2018-01-01 – 2018-12-31: -6355838 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · enVVeno Medical Corporation · 2018-12-31 enVVeno Medical Corporation (edgar:1661053) Operating Cash Flow: -6355838 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:57:08Z Snapshot: cbf24923a26c38816f33be15db6db6f84dba035d4c14f6dddae1b801f75c518c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1661053/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6355838 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1661053/000149315220023963/hjli-20200930.xml#345429 Filing: 000149315220023963 The citation records this snapshot. The page link may show a newer release later.	USD 12,422 Exact value Exact value: 12422 USD 2018-01-01 – 2018-12-31: 12422 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · enVVeno Medical Corporation · 2018-12-31 enVVeno Medical Corporation (edgar:1661053) Capital Expenditure: 12422 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:57:08Z Snapshot: cbf24923a26c38816f33be15db6db6f84dba035d4c14f6dddae1b801f75c518c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1661053/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 12422 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1661053/000149315220023963/hjli-20200930.xml#360106 Filing: 000149315220023963 The citation records this snapshot. The page link may show a newer release later.	−USD 6.37 million Calculation and evidence -6355838 − 12422 USD Exact free cash flow: -6368260 USD 2018-01-01 – 2018-12-31: -6355838 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 12422 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · enVVeno Medical Corporation · 2018-12-31 enVVeno Medical Corporation (edgar:1661053) Free cash flow: -6368260 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:57:08Z Snapshot: cbf24923a26c38816f33be15db6db6f84dba035d4c14f6dddae1b801f75c518c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1661053?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6355838 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1661053/000149315220023963/hjli-20200930.xml#345429 Filing: 000149315220023963 Input fundies:CapitalExpenditure: 12422 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1661053/000149315220023963/hjli-20200930.xml#360106 Filing: 000149315220023963 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 7.63 million Exact value Exact value: -7625397 USD 2019-01-01 – 2019-12-31: -7625397 USD Inspect Net Income Open source Share or cite Citation for Net Income · enVVeno Medical Corporation · 2019-12-31 enVVeno Medical Corporation (edgar:1661053) Net Income: -7625397 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:57:08Z Snapshot: cbf24923a26c38816f33be15db6db6f84dba035d4c14f6dddae1b801f75c518c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1661053/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -7625397 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1661053/000149315221007526/hjli-20201231.xml#656971 Filing: 000149315221007526 The citation records this snapshot. The page link may show a newer release later.	−USD 5.9 million Exact value Exact value: -5896400 USD 2019-01-01 – 2019-12-31: -5896400 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · enVVeno Medical Corporation · 2019-12-31 enVVeno Medical Corporation (edgar:1661053) Operating Cash Flow: -5896400 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:57:08Z Snapshot: cbf24923a26c38816f33be15db6db6f84dba035d4c14f6dddae1b801f75c518c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1661053/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5896400 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1661053/000149315221007526/hjli-20201231.xml#360257 Filing: 000149315221007526 The citation records this snapshot. The page link may show a newer release later.	USD 363,891 Exact value Exact value: 363891 USD 2019-01-01 – 2019-12-31: 363891 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · enVVeno Medical Corporation · 2019-12-31 enVVeno Medical Corporation (edgar:1661053) Capital Expenditure: 363891 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:57:08Z Snapshot: cbf24923a26c38816f33be15db6db6f84dba035d4c14f6dddae1b801f75c518c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1661053/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 363891 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1661053/000149315221007526/hjli-20201231.xml#364153 Filing: 000149315221007526 The citation records this snapshot. The page link may show a newer release later.	−USD 6.26 million Calculation and evidence -5896400 − 363891 USD Exact free cash flow: -6260291 USD 2019-01-01 – 2019-12-31: -5896400 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 363891 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · enVVeno Medical Corporation · 2019-12-31 enVVeno Medical Corporation (edgar:1661053) Free cash flow: -6260291 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:57:08Z Snapshot: cbf24923a26c38816f33be15db6db6f84dba035d4c14f6dddae1b801f75c518c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1661053?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5896400 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1661053/000149315221007526/hjli-20201231.xml#360257 Filing: 000149315221007526 Input fundies:CapitalExpenditure: 363891 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1661053/000149315221007526/hjli-20201231.xml#364153 Filing: 000149315221007526 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 9.14 million Exact value Exact value: -9135486 USD 2020-01-01 – 2020-12-31: -9135486 USD Inspect Net Income Open source Share or cite Citation for Net Income · enVVeno Medical Corporation · 2020-12-31 enVVeno Medical Corporation (edgar:1661053) Net Income: -9135486 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:57:08Z Snapshot: cbf24923a26c38816f33be15db6db6f84dba035d4c14f6dddae1b801f75c518c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1661053/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -9135486 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1661053/000149315222007802/form10-k.htm#965617 Filing: 000149315222007802 The citation records this snapshot. The page link may show a newer release later.	−USD 7.68 million Exact value Exact value: -7677210 USD 2020-01-01 – 2020-12-31: -7677210 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · enVVeno Medical Corporation · 2020-12-31 enVVeno Medical Corporation (edgar:1661053) Operating Cash Flow: -7677210 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:57:08Z Snapshot: cbf24923a26c38816f33be15db6db6f84dba035d4c14f6dddae1b801f75c518c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1661053/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7677210 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1661053/000149315222007802/form10-k.htm#978425 Filing: 000149315222007802 The citation records this snapshot. The page link may show a newer release later.	USD 180,291 Exact value Exact value: 180291 USD 2020-01-01 – 2020-12-31: 180291 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · enVVeno Medical Corporation · 2020-12-31 enVVeno Medical Corporation (edgar:1661053) Capital Expenditure: 180291 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:57:08Z Snapshot: cbf24923a26c38816f33be15db6db6f84dba035d4c14f6dddae1b801f75c518c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1661053/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 180291 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1661053/000149315222007802/form10-k.htm#980384 Filing: 000149315222007802 The citation records this snapshot. The page link may show a newer release later.	−USD 7.86 million Calculation and evidence -7677210 − 180291 USD Exact free cash flow: -7857501 USD 2020-01-01 – 2020-12-31: -7677210 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 180291 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · enVVeno Medical Corporation · 2020-12-31 enVVeno Medical Corporation (edgar:1661053) Free cash flow: -7857501 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:57:08Z Snapshot: cbf24923a26c38816f33be15db6db6f84dba035d4c14f6dddae1b801f75c518c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1661053?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7677210 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1661053/000149315222007802/form10-k.htm#978425 Filing: 000149315222007802 Input fundies:CapitalExpenditure: 180291 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1661053/000149315222007802/form10-k.htm#980384 Filing: 000149315222007802 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 16.53 million Exact value Exact value: -16528000 USD 2021-01-01 – 2021-12-31: -16528000 USD Inspect Net Income Open source Share or cite Citation for Net Income · enVVeno Medical Corporation · 2021-12-31 enVVeno Medical Corporation (edgar:1661053) Net Income: -16528000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:57:08Z Snapshot: cbf24923a26c38816f33be15db6db6f84dba035d4c14f6dddae1b801f75c518c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1661053/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -16528000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1661053/000149315223006587/form10-k.htm#990070 Filing: 000149315223006587 The citation records this snapshot. The page link may show a newer release later.	−USD 11.85 million Exact value Exact value: -11848000 USD 2021-01-01 – 2021-12-31: -11848000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · enVVeno Medical Corporation · 2021-12-31 enVVeno Medical Corporation (edgar:1661053) Operating Cash Flow: -11848000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:57:08Z Snapshot: cbf24923a26c38816f33be15db6db6f84dba035d4c14f6dddae1b801f75c518c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1661053/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -11848000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1661053/000149315223006587/form10-k.htm#1002708 Filing: 000149315223006587 The citation records this snapshot. The page link may show a newer release later.	USD 368,000 Exact value Exact value: 368000 USD 2021-01-01 – 2021-12-31: 368000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · enVVeno Medical Corporation · 2021-12-31 enVVeno Medical Corporation (edgar:1661053) Capital Expenditure: 368000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:57:08Z Snapshot: cbf24923a26c38816f33be15db6db6f84dba035d4c14f6dddae1b801f75c518c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1661053/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 368000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1661053/000149315223006587/form10-k.htm#1005360 Filing: 000149315223006587 The citation records this snapshot. The page link may show a newer release later.	−USD 12.22 million Calculation and evidence -11848000 − 368000 USD Exact free cash flow: -12216000 USD 2021-01-01 – 2021-12-31: -11848000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 368000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · enVVeno Medical Corporation · 2021-12-31 enVVeno Medical Corporation (edgar:1661053) Free cash flow: -12216000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:57:08Z Snapshot: cbf24923a26c38816f33be15db6db6f84dba035d4c14f6dddae1b801f75c518c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1661053?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -11848000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1661053/000149315223006587/form10-k.htm#1002708 Filing: 000149315223006587 Input fundies:CapitalExpenditure: 368000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1661053/000149315223006587/form10-k.htm#1005360 Filing: 000149315223006587 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 24.67 million Exact value Exact value: -24669000 USD 2022-01-01 – 2022-12-31: -24669000 USD Inspect Net Income Open source Share or cite Citation for Net Income · enVVeno Medical Corporation · 2022-12-31 enVVeno Medical Corporation (edgar:1661053) Net Income: -24669000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:57:08Z Snapshot: cbf24923a26c38816f33be15db6db6f84dba035d4c14f6dddae1b801f75c518c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1661053/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -24669000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1661053/000149315224008336/form10-k.htm#941305 Filing: 000149315224008336 The citation records this snapshot. The page link may show a newer release later.	−USD 15.62 million Exact value Exact value: -15619000 USD 2022-01-01 – 2022-12-31: -15619000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · enVVeno Medical Corporation · 2022-12-31 enVVeno Medical Corporation (edgar:1661053) Operating Cash Flow: -15619000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:57:08Z Snapshot: cbf24923a26c38816f33be15db6db6f84dba035d4c14f6dddae1b801f75c518c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1661053/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -15619000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1661053/000149315224008336/form10-k.htm#952293 Filing: 000149315224008336 The citation records this snapshot. The page link may show a newer release later.	USD 115,000 Exact value Exact value: 115000 USD 2022-01-01 – 2022-12-31: 115000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · enVVeno Medical Corporation · 2022-12-31 enVVeno Medical Corporation (edgar:1661053) Capital Expenditure: 115000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:57:08Z Snapshot: cbf24923a26c38816f33be15db6db6f84dba035d4c14f6dddae1b801f75c518c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1661053/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 115000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1661053/000149315224008336/form10-k.htm#956296 Filing: 000149315224008336 The citation records this snapshot. The page link may show a newer release later.	−USD 15.73 million Calculation and evidence -15619000 − 115000 USD Exact free cash flow: -15734000 USD 2022-01-01 – 2022-12-31: -15619000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 115000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · enVVeno Medical Corporation · 2022-12-31 enVVeno Medical Corporation (edgar:1661053) Free cash flow: -15734000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:57:08Z Snapshot: cbf24923a26c38816f33be15db6db6f84dba035d4c14f6dddae1b801f75c518c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1661053?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -15619000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1661053/000149315224008336/form10-k.htm#952293 Filing: 000149315224008336 Input fundies:CapitalExpenditure: 115000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1661053/000149315224008336/form10-k.htm#956296 Filing: 000149315224008336 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 23.52 million Exact value Exact value: -23516000 USD 2023-01-01 – 2023-12-31: -23516000 USD Inspect Net Income Open source Share or cite Citation for Net Income · enVVeno Medical Corporation · 2023-12-31 enVVeno Medical Corporation (edgar:1661053) Net Income: -23516000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:57:08Z Snapshot: cbf24923a26c38816f33be15db6db6f84dba035d4c14f6dddae1b801f75c518c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1661053/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -23516000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1661053/000149315225008739/form10-ka.htm#1252730 Filing: 000149315225008739 The citation records this snapshot. The page link may show a newer release later.	−USD 18.86 million Exact value Exact value: -18858000 USD 2023-01-01 – 2023-12-31: -18858000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · enVVeno Medical Corporation · 2023-12-31 enVVeno Medical Corporation (edgar:1661053) Operating Cash Flow: -18858000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:57:08Z Snapshot: cbf24923a26c38816f33be15db6db6f84dba035d4c14f6dddae1b801f75c518c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1661053/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -18858000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1661053/000149315225008739/form10-ka.htm#943534 Filing: 000149315225008739 The citation records this snapshot. The page link may show a newer release later.	USD 33,000 Exact value Exact value: 33000 USD 2023-01-01 – 2023-12-31: 33000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · enVVeno Medical Corporation · 2023-12-31 enVVeno Medical Corporation (edgar:1661053) Capital Expenditure: 33000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:57:08Z Snapshot: cbf24923a26c38816f33be15db6db6f84dba035d4c14f6dddae1b801f75c518c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1661053/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 33000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1661053/000149315225008739/form10-ka.htm#947525 Filing: 000149315225008739 The citation records this snapshot. The page link may show a newer release later.	−USD 18.89 million Calculation and evidence -18858000 − 33000 USD Exact free cash flow: -18891000 USD 2023-01-01 – 2023-12-31: -18858000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 33000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · enVVeno Medical Corporation · 2023-12-31 enVVeno Medical Corporation (edgar:1661053) Free cash flow: -18891000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:57:08Z Snapshot: cbf24923a26c38816f33be15db6db6f84dba035d4c14f6dddae1b801f75c518c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1661053?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -18858000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1661053/000149315225008739/form10-ka.htm#943534 Filing: 000149315225008739 Input fundies:CapitalExpenditure: 33000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1661053/000149315225008739/form10-ka.htm#947525 Filing: 000149315225008739 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 21.82 million Exact value Exact value: -21819000 USD 2024-01-01 – 2024-12-31: -21819000 USD Inspect Net Income Open source Share or cite Citation for Net Income · enVVeno Medical Corporation · 2024-12-31 enVVeno Medical Corporation (edgar:1661053) Net Income: -21819000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T13:57:08Z Snapshot: cbf24923a26c38816f33be15db6db6f84dba035d4c14f6dddae1b801f75c518c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1661053/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -21819000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1661053/000149315226012928/form10-k.htm#1289604 Filing: 000149315226012928 The citation records this snapshot. The page link may show a newer release later.	−USD 16.84 million Exact value Exact value: -16838000 USD 2024-01-01 – 2024-12-31: -16838000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · enVVeno Medical Corporation · 2024-12-31 enVVeno Medical Corporation (edgar:1661053) Operating Cash Flow: -16838000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T13:57:08Z Snapshot: cbf24923a26c38816f33be15db6db6f84dba035d4c14f6dddae1b801f75c518c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1661053/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -16838000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1661053/000149315226012928/form10-k.htm#939775 Filing: 000149315226012928 The citation records this snapshot. The page link may show a newer release later.	USD 37,000 Exact value Exact value: 37000 USD 2024-01-01 – 2024-12-31: 37000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · enVVeno Medical Corporation · 2024-12-31 enVVeno Medical Corporation (edgar:1661053) Capital Expenditure: 37000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T13:57:08Z Snapshot: cbf24923a26c38816f33be15db6db6f84dba035d4c14f6dddae1b801f75c518c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1661053/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 37000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1661053/000149315226012928/form10-k.htm#943765 Filing: 000149315226012928 The citation records this snapshot. The page link may show a newer release later.	−USD 16.88 million Calculation and evidence -16838000 − 37000 USD Exact free cash flow: -16875000 USD 2024-01-01 – 2024-12-31: -16838000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 37000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · enVVeno Medical Corporation · 2024-12-31 enVVeno Medical Corporation (edgar:1661053) Free cash flow: -16875000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T13:57:08Z Snapshot: cbf24923a26c38816f33be15db6db6f84dba035d4c14f6dddae1b801f75c518c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1661053?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -16838000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1661053/000149315226012928/form10-k.htm#939775 Filing: 000149315226012928 Input fundies:CapitalExpenditure: 37000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1661053/000149315226012928/form10-k.htm#943765 Filing: 000149315226012928 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−USD 19.47 million Exact value Exact value: -19472000 USD 2025-01-01 – 2025-12-31: -19472000 USD Inspect Net Income Open source Share or cite Citation for Net Income · enVVeno Medical Corporation · 2025-12-31 enVVeno Medical Corporation (edgar:1661053) Net Income: -19472000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:57:08Z Snapshot: cbf24923a26c38816f33be15db6db6f84dba035d4c14f6dddae1b801f75c518c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1661053/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -19472000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1661053/000149315226012928/form10-k.htm#1288680 Filing: 000149315226012928 The citation records this snapshot. The page link may show a newer release later.	−USD 15.57 million Exact value Exact value: -15568000 USD 2025-01-01 – 2025-12-31: -15568000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · enVVeno Medical Corporation · 2025-12-31 enVVeno Medical Corporation (edgar:1661053) Operating Cash Flow: -15568000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:57:08Z Snapshot: cbf24923a26c38816f33be15db6db6f84dba035d4c14f6dddae1b801f75c518c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1661053/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -15568000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1661053/000149315226012928/form10-k.htm#939304 Filing: 000149315226012928 The citation records this snapshot. The page link may show a newer release later.	USD 5,000 Exact value Exact value: 5000 USD 2025-01-01 – 2025-12-31: 5000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · enVVeno Medical Corporation · 2025-12-31 enVVeno Medical Corporation (edgar:1661053) Capital Expenditure: 5000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:57:08Z Snapshot: cbf24923a26c38816f33be15db6db6f84dba035d4c14f6dddae1b801f75c518c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1661053/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1661053/000149315226012928/form10-k.htm#943308 Filing: 000149315226012928 The citation records this snapshot. The page link may show a newer release later.	−USD 15.57 million Calculation and evidence -15568000 − 5000 USD Exact free cash flow: -15573000 USD 2025-01-01 – 2025-12-31: -15568000 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 5000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · enVVeno Medical Corporation · 2025-12-31 enVVeno Medical Corporation (edgar:1661053) Free cash flow: -15573000 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:57:08Z Snapshot: cbf24923a26c38816f33be15db6db6f84dba035d4c14f6dddae1b801f75c518c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1661053?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -15568000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1661053/000149315226012928/form10-k.htm#939304 Filing: 000149315226012928 Input fundies:CapitalExpenditure: 5000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1661053/000149315226012928/form10-k.htm#943308 Filing: 000149315226012928 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

53 filings · 1,702 latest values · 1,702 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001661053, 1661053, HJLI, NVNO, edgar:1661053

Also known as Hancock Jaffe Laboratories, Inc., enVVeno Medical Corporation, enVVeno Medical Corp, enVVeno Medical Corporation

enVVeno Medical Corporation

Latest quarter

Revenue

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2019 2019-01-01 – 2019-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation